21 May 2013
Keywords: s-p, posaconazole, nda, accepted, fda, review, food
Article | 19 July 2004
The US Food and Drug Administration has accepted for reviewSchering-Plough's New Drug Application for posaconazole oral suspension.
The agent is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2004
20 May 2013
© 2013 thepharmaletter.com